Your session is about to expire
← Back to Search
Intention Treatment for Aphasia
N/A
Recruiting
Led By Amy D. Rodriguez, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Presence of word retrieval deficits
Diagnosis of aphasia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 6 months; change from baseline to 3 weeks (post massed-int) or 12 weeks (post distributed-int), change at 3 months post-treatment, change at 6 months post-treatment
Awards & highlights
Study Summary
This trial is investigating a new word retrieval treatment for Veterans with aphasia caused by stroke, to see if it is more effective than the current standard of care.
Who is the study for?
This trial is for Veterans who primarily speak English, have aphasia with difficulty finding words after a stroke in the left side of the brain, and can follow two-step commands. It's not for those with implanted medical devices or metal in their bodies, severe speech muscle control issues, or major depression.Check my eligibility
What is being tested?
The study tests a new word retrieval treatment for aphasia following a stroke. Researchers aim to find out how intense this therapy should be and what factors predict success in improving language skills among Veterans.See study design
What are the potential side effects?
Since this is a non-drug intervention focusing on language therapy post-stroke, traditional medication side effects are not expected. However, participants may experience fatigue or frustration during intensive language exercises.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I struggle to find the right words when speaking.
Select...
I have been diagnosed with aphasia.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study study completion, an average of 6 months; change from baseline to 3 weeks (post m-int) or 12 weeks (post d-int), change at 3 months post-treatment, change at 6 months post-treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study study completion, an average of 6 months; change from baseline to 3 weeks (post m-int) or 12 weeks (post d-int), change at 3 months post-treatment, change at 6 months post-treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Boston Naming Test
Brief Visuospatial Memory Test-Revised
Delis?Kaplan Executive Function System (D-KEFS) Sorting
+8 moreSecondary outcome measures
Delis?Kaplan Executive Function System (D-KEFS) Trails
Trial Design
2Treatment groups
Active Control
Group I: Distributed Intention Treatment (distributed-INT)Active Control1 Intervention
Participants will receive 30 hours of Intention Treatment (INT) over 12 weeks.
Group II: Massed Intention Treatment (massed-INT)Active Control1 Intervention
Participants will receive 30 hours of Intention Treatment (INT) over 3 weeks.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,610 Previous Clinical Trials
3,305,144 Total Patients Enrolled
83 Trials studying Stroke
6,678 Patients Enrolled for Stroke
Amy D. Rodriguez, PhDPrincipal InvestigatorAtlanta VA Medical and Rehab Center, Decatur, GA
2 Previous Clinical Trials
40 Total Patients Enrolled
1 Trials studying Stroke
12 Patients Enrolled for Stroke
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I don't have metal implants, devices, or severe fear of tight spaces.I struggle to find the right words when speaking.I can understand and follow two-step commands.I have severe difficulty speaking clearly.It's been 6 months since my stroke, which was in the left side of my brain.I have been diagnosed with aphasia.I have been diagnosed with severe depression.
Research Study Groups:
This trial has the following groups:- Group 1: Distributed Intention Treatment (distributed-INT)
- Group 2: Massed Intention Treatment (massed-INT)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the present enrollment capacity for this trial?
"Indeed, the clinicaltrial.gov website confirms that as of 1/27/2022 this medical experiment is still open for enrollment. It was initially posted on 5/24/2021 and requires 40 participants to be recruited from one location."
Answered by AI
Is there an opportunity to enroll in this experiment?
"This research is recruiting 40 individuals under the age of 89, that have suffered a stroke. Qualifying patients must be between 21 and 89 years old."
Answered by AI
Are there any vacancies for participation in this experiment?
"According to the info on clinicaltrials.gov, this research project is still in search of patients; it was originally unveiled on May 24th 2021 and was recently updated on January 27th 2022."
Answered by AI
Is the upper age limit for this clinical experiment restricted to 80 years of age?
"This medical trial is open to applicants aged 21-89, however there are separate trials for those below the age of consent and those over 65 years old respectively. Specifically, 42 studies exist for minors while 1063 are available to older people."
Answered by AI
Recent research and studies
Popular Categories
Share this study with friends
Copy Link
Messenger